A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma
Journal of immunotherapy (Hagerstown, Md. : 1997)- United States
doi 10.1097/00002371-200407000-00001
Full Text
Abstract
Available in
Date
January 1, 2004
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)